Is NeuroScientific Biopharmaceuticals Ltd halal to invest in?

According to Musaffa's Shariah screening methodology, NeuroScientific Biopharmaceuticals Ltd (NSB.AX) is currently classified as NOT HALAL as of July 2025. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is NeuroScientific Biopharmaceuticals Ltd a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes NeuroScientific Biopharmaceuticals Ltd using these criteria to determine its compliance status.

Can Muslims buy shares of NeuroScientific Biopharmaceuticals Ltd?

Muslim investors may consider investing in NeuroScientific Biopharmaceuticals Ltd if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is NeuroScientific Biopharmaceuticals Ltd classified as NOT HALAL?

Musaffa determines the Shariah status of NeuroScientific Biopharmaceuticals Ltd by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for NeuroScientific Biopharmaceuticals Ltd updated?

The Shariah compliance status of NeuroScientific Biopharmaceuticals Ltd may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like NeuroScientific Biopharmaceuticals Ltd become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of NeuroScientific Biopharmaceuticals Ltd?

You can check the latest Shariah compliance status of NeuroScientific Biopharmaceuticals Ltd on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

NSB.AX Shariah Compliance

Screening Methodology: AAOIFI

NOT HALAL

Last Updated: July 30, 2025

Report Source: 2025 2nd Quarter Report

NeuroScientific Biopharmaceuticals Ltd. Stock Analysis NSB.AX

Australia Health Care Nano Cap Report: Q2, 2025

Neuroscientific Biopharmaceuticals Ltd. engages in researching and developing biomedical products targeting neurodegenerative conditions. The company is headquartered in Perth, Western Australia. The company went IPO on 2018-07-27. The firm's product portfolio includes EmtinB, a therapeutic peptide initially targeting glaucoma, as well as other Emtin peptides (EmtinAc, EmtinAn and EmtinBn). EmtinB is a peptide-based compound that binds to surface-based cell receptors from the LDLR family, activating intracellular signalling pathways that stimulate neuroprotection, neuroregeneration and modulate neuroinflammation. EmtinB is modelled on a specific active domain of the complex human protein called Metallothionein-IIA, which is produced as part of the human body's innate immune response to cell injury. Its StemSmart is a global patented technology engaged in manufacturing cell products. The use of its proprietary StemSmart technology in a special access program for fistulising Crohn’s disease.

Key Statistics of NeuroScientific Biopharmaceuticals Ltd (NSB.AX)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

AUD0.10AUD0.10

Today's Open

AUD0.10

Volume

140.36K

P/E Ratio (TTM)

52 Week Range

AUD0.05AUD0.26

Market Cap

34.92M

Avg. Volume

197.08K

Dividend Yield

Financial Metrics & Statements of NeuroScientific Biopharmaceuticals Ltd (NSB.AX)

FAQ's for NeuroScientific Biopharmaceuticals Ltd (NSB.AX)

According to Musaffa’s Shariah screening methodology, NeuroScientific Biopharmaceuticals Ltd (NSB.AX) is currently classified as NOT HALAL as of July 2025. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.